Amgen Inc. buy Piper Sandler
Start price
02.01.25
/
50%
€254.50
Target price
02.01.26
€300.51
Performance (%)
16.24%
Price
13.11.25
€288.80
Summary
This prediction is currently active. The prediction currently has a performance of 16.24%. Dividends of €7.03 are taken into consideration when calculating the performance. This prediction currently runs until 02.01.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 5.671% | 5.671% |
| iShares Core DAX® | 1.343% | -1.493% |
| iShares Nasdaq 100 | -1.235% | 0.457% |
| iShares Nikkei 225® | -2.386% | 4.669% |
| iShares S&P 500 | -0.486% | 0.800% |
Comments by Piper_Sandler for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its price target lowered by analysts at Piper Sandler from $344.00 to $310.00. They now have an "overweight" rating on the stock.
Ratings data for AMGN provided by MarketBeat